Journals / Türk Kardiyoloji Derneği Arşivi / 2009 / Cilt: 37 - Sayı: 6

Endomyocardial fibrosis causing right intraventricular gradient and obliteration

Sağ ventrikül içi basınç gradiyentine ve obliterasyona neden olan endomiyokardiyal fibrozis

Pages
417–420
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The presented case may arouse interest in that increased tissue growth in the right ventricle inflow region caused a gradient in the right ventricle, leading to an incorrect diagnosis, at another center, as idiopathic pulmonary hypertension.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Endomyocardial fibrosis is a cause of restrictive cardiomyopathy and it generally occurs in tropical regions more commonly affecting children and young adults.
📊
Key Findings & Data:A 19-year-old male patient presented with edema in the lower extremities and fatigue.
💡
Conclusion & Impact:The presented case may arouse interest in that increased tissue growth in the right ventricle inflow region caused a gradient in the right ventricle, leading to an incorrect diagnosis, at another center, as idiopathic pulmonary hypertension.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Endomyocardial fibrosis is a cause of restrictive cardiomyopathy and it generally occurs in tropical regions more commonly affecting children and young adults. A 19-year-old male patient presented with edema in the lower extremities and fatigue. Transthoracic echocardiography showed dilated right heart chambers, restrictive physiology in the left ventricle, and increased tissue growth in the right ventricle that caused a 60-mmHg gradient and obliteration. Magnetic resonance imaging confirmed the presence of increased tissue formation in the right ventricular inflow region. Surgical resection was not considered taking into account the functional capacity of the patient (class II), disappearance of symptoms following medical treatment, and the high risk for operative mortality. The presented case may arouse interest in that increased tissue growth in the right ventricle inflow region caused a gradient in the right ventricle, leading to an incorrect diagnosis, at another center, as idiopathic pulmonary hypertension.

Özet

Restriktif kardiyomiyopatiye neden olan endomiyokardiyal fibrozis tropik iklimlerde sık gözlenir ve genellikle çocuklarda ve genç erişkinlerde görülür. Bacaklarda şişlik ve çabuk yorulma yakınması ile başvuran 19 yaşındaki erkek hastanın transtorasik ekokardiyografisinde sağ kalp boyutlarında genişleme, sol ventrikülde restriktif akım örneği, sağ ventrikül içinde 60 mmHg gradiyent yaratan ve obliterasyona neden olan doku yoğunlaşması saptandı ve manyetik rezonans görüntülemede sağ ventrikül giriş bölgesinde doku artışı izlendi. Hastanın sınıf II düzeyindeki fonksiyonel kapasitesi, medikal tedaviye iyi yanıt alınması ve ameliyat mortalitesi riskinin yüksek olması nedeniyle cerrahi rezeksiyon düşünülmedi. Sunulan olgunun en ilginç noktası, sağ ventrikül giriş bölgesindeki doku yoğunluğunun obstrüksiyona neden olarak sağ ventrikül içinde basınç farkı yaratması ve bu durumun başka bir merkezde idiyopatik pulmoner hipertansiyon olarak değerlendirilmesine yol açmış olmasıdır.

🔖

Cite This Article

TAÇOY, G., TAVİL, Y., ABACI, A. (2022). Endomyocardial fibrosis causing right intraventricular gradient and obliteration. Türk Kardiyoloji Derneği Arşivi, Cilt: 37 - Sayı: 6, 417–420. https://ajindex.com/articles/633416

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hutt MS. Epidemiology aspects of endomyocardial fibrosis. Postgrad Med J 1983;59:142-6
  2. Uçar O, Gölbaşı Z, Yıldırım N. Two cases of endomyocardial disease with hypereosinophilia in Turkey. Eur J Echocardiogr 2005;6:379-81
  3. Rutakingirwa M, Ziegler JL, Newton R, Freers J. Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop Med Int Health 1999;4:229-35
  4. Yılmaz E, Güvenç S, Kocaman O, Kıyan E. Acute severe myocarditis in a woman with hypereosinophilic syndrome. [Article in Turkish] Türk Kardiyol Dern Arş 2002;30:265-8
  5. Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J 1989;62:450-4
  6. Saraçlar M, Özer S, Öztunç F, Çeliker A. Echocardiographic findings in endomyocardial fibrosis. Turk J Pediatr 1992;34:47-53
  7. Falase AO. Aetiological considerations in Nigeria. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial fibrosis. Oxford: Oxford University Press; 1993. p. 88-94
  8. Acquatella H, Schiller NB, Puigbó JJ, Gómez-Mancebo JR, Suarez C, Acquatella G. Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study. Circulation 1983;67:1219-26
  9. Berensztein CS, Piñeiro D, Marcotegui M, Brunoldi R, Blanco MV, Lerman J. Usefulness of echocardiography and Doppler echocardiography in endomyocardial fibrosis. J Am Soc Echocardiogr 2000;13:385-92
  10. Aso H, Takeda K, Ito T, Shiraishi T, Matsumura K, Nakagawa T. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 1998;33:22-32
  11. Somers K, Hutt MS, Patel AK, D’Arbela PG. Endomyocardial biopsy in diagnosis of cardiomyopathies. Br Heart J 1971;33:822-32
  12. Metras D, Coulibaly AO, Ouattara K. The surgical treatment of endomyocardial fibrosis: results in 55 patients. Circulation 1985;72(3 Pt 2):II274-9
  13. Metras D. Endomyocardial fibrosis and its surgical treatment: Ivory Coast experience. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial fibrosis. Oxford: Oxford University Press; 1993. p. 207-19
  14. Valiathan MS, Balakrishnan KG, Sankarkumar R, Kartha CC. Surgical treatment of endomyocardial fibrosis. Ann Thorac Surg 1987;43:68-73.